Finerenone was associated with significantly smaller mean increases in serum potassium concentration and lower incidences of hyperkalemia than spironolactoneFinerenone also decreased the levels of BNP, NT-proBNP, and albuminuria at least as much as spironolactoneIncidence of hyperkalemia with finerenone 5 or 10 mg significantly smaller versus spironolactone. This evidence concerns the gene NPPB and Hyperkalemia.